POLYPEPTIDES D'ÉRYTHROPOÏÉTINE MODIFIÉS ET UTILISATION DE CEUX-CI DANS DES TRAITEMENTS

• 收藏
• 分享

专利权人:

HANALL BIOPHARMA CO.; LTD.

发明人:

申请号：

EP07824714.5

公开号：

EP2120998B1

申请日:

2007.11.27

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

Modified erythropoietin (EPO) polypeptides and other modified therapeutic polypeptides are provided. The EPO polypeptides and other therapeutic polypeptides are modified to exhibit physical properties and activities that differ from the unmodified EPO polypeptides and other unmodified therapeutic polypeptides, respectively. Nucleic acid molecules encoding these polypeptides also are provided. Also provided are methods of treatment and diagnosis using the polypeptides.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/